Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04602117
Title Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors QuantumLeap Healthcare Collaborative
Indications

transitional cell carcinoma

Her2-receptor positive breast cancer

endometrial cancer

colorectal cancer

gastroesophageal adenocarcinoma

ovarian cancer

Therapies

Paclitaxel + Trastuzumab Duocarmazine

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.